Assyro AI

FDA Orange Book · active-ingredient family

Ethinyl estradiol; ethynodiol diacetate

Ethinyl estradiol; ethynodiol diacetate is approved as 4 brand and 9 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:DEMULEN 1/35-21 · NDA 018168

4

Brand (NDA)

9

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
DEMULEN 1/35-21GD SEARLE LLCNDA 018168Approved Prior to Jan 1, 1982
DEMULEN 1/50-21GD SEARLE LLCNDA 016927Approved Prior to Jan 1, 1982
DEMULEN 1/35-28GD SEARLE LLCNDA 018160Approved Prior to Jan 1, 1982
DEMULEN 1/50-28GD SEARLE LLCNDA 016936Approved Prior to Jan 1, 1982

Generic (ANDA) products (9)

ProductApplicantApplicationTEApproved
LO-MALMOREDENOVAST LABSANDA 209548ABFeb 11, 2019
MALMOREDENOVAST LABSANDA 209547ABJul 25, 2018
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOLXIROMEDANDA 204703ABJul 28, 2016
ETHYNODIOL DIACETATE AND ETHINYL ESTRADIOLXIROMEDANDA 204704ABFeb 09, 2016
KELNORBARRANDA 076785ABMay 23, 2005
ZOVIA 1/35E-21WATSON PHARMS TEVAANDA 072720Dec 30, 1991
ZOVIA 1/50E-21WATSON LABSANDA 072722Dec 30, 1991
KELNOR 1/50WATSON LABSANDA 072723Dec 30, 1991
ZOVIA 1/35E-28DR REDDYS LABS SAANDA 072721Dec 30, 1991

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Ethinyl estradiol; ethynodiol diacetate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.